ARTICLE | Company News
Management Tracks: Biohaven, Selecta
October 30, 2017 10:42 PM UTC
Neurology company Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) hired Clifford Bechtold as COO. He was development team leader for genetically defined diseases at Bristol-Myers Squibb Co. (NYSE:BMY).
Immunology company Selecta Biosciences Inc. (NASDAQ:SELB) hired John Leaman as CFO and head of corporate strategy. He was head of corporate development at InfaCare Pharmaceutical Corp., which Mallinckrodt plc (NYSE:MNK) acquired. Selecta also named Stephen Smolinski CCO. He was VP and head of the North American rheumatology business unit at the Genzyme unit of Sanofi (Euronext:SAN; NYSE:SNY)...